Drug recall · February 7, 2018
Glenmark Mometasone Furoate Cream recall
Why: CGMP Deviations: Market complaints related to "gritty texture".
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Glenmark Mometasone Furoate Cream, USP, 0.1%, 45 g Rx Only Manufactured by: Glenmark Pharmaceuticals Ltd. Village Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 NDC 68462019255 UPC 3684620192559
- Lots / codes
Batch Number: 05170598; Exp. 03/19
- Quantity
- 5136 tubes
- Company
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ
- Distribution
- Product was distributed throughout the United States.
- Initiated
- November 20, 2017 · Voluntary: Firm initiated
- Classified
- February 7, 2018
- Reported
- February 7, 2018
- Ended
- October 3, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Mometasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.